Clinical Trial

Milk Consumption and Blood Microbiome in Healthy Volunteers

Study acronym: MAMI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to learn if cfDNA of milk-associated intestinal bacteria (MAIB) is detectable in the bloodstream. The primary question it aims to answer is: \- Does milk consumption simultaneously increase the number of MAIB cfDNA counts in blood samples, as it does in fecal samples? Researchers will compare cfDNA counts of MAIB to those of fecal samples to assess whether the blood microbiome is a valid measure of the gut microbiome, utilizing a self-developed bioinformatics pipeline. Participants will: * Abstain from consuming any dairy products for ten days, followed by drinking milk for 7 consecutive days. * Provide blood and fecal samples before dairy abstinence, as well as at 0, 24, and 48 hours, and one week after the reintroduction of milk.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-17; most recent amendment 2025-08-04.
Status change: Not Yet Recruiting → Recruiting 2025-06-10
Trial Details
NCT Number NCT06944002
Lead Sponsor Erasmus Medical Center
Collaborators: NWO (Dutch Organisation for Scientific Research)
Conditions Healthy
Enrollment 10 participants
Start Date 2025-07-10
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2025-08-07